Labeling: Incorrect or Missing Lot and/or Exp. Date
Prescription Drugs
💊 Drugs • 12,141 recalls
Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.
LaBri's Body Health Atomic 60 Capsules Exclusively distributed worldwide by LaBri's Body Health.
EZWeightLossTX
Marketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary Supplements: products found to be tainted with sibutramine making these unapproved drugs.
LaBri's Body Health XPLODE 30 capsules Exclusively distribute worldwide by LaBri's Body Health.
EZWeightLossTX
Marketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary Supplements: products found to be tainted with sibutramine making these unapproved drugs.
Presence of Particulate Matter: glass particulate found in vial
Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.
Methylphenidate Hydrochloride Extended-release Tablets, USP 27 mg, 100-count bottles, Rx Only, Trigen Laboratories, LLC. Bridgewater, NJ 08807, NDC 13811-707-10
Osmotica Pharmaceutical
Subpotent Drug
Subpotent Drug: found to be below the specification for labeled assay.
Superpotent
Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.
Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.
Subpotent Drug: found to be below the specification for labeled assay.
Superpotent
Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.
Labeling: Incorrect Instructions. "TABLETS IN WEEK 4 ARE INACTIVE" printed on the blister foil and package insert, however,all tablets are active.
Methylphenidate Hydrochloride Extended-release Tablets, USP 54 mg, 100-count bottles, Rx Only, Trigen Laboratories, LLC. Bridgewater, NJ 08807, NDC 13811-709-10
Osmotica Pharmaceutical
Subpotent Drug
Lorazepam Oral Concentrate, USP, 2 mg/mL, 30 mL bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Branchburg, NJ 08876. Distributed by: Amneal Pharmaceuticals, Glasgow, KY 42141. NDC 65162-687-84
Amneal Pharmaceuticals of New York
Defective Delivery System: the dropper measurement markings may be reversed, shifted or missing.
Subpotent Drug: found to be below the specification for labeled assay.
Microbial Contamination of Non-Sterile Products
Microbial Contamination of Non-Sterile Products